In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orion Corporation

https://www.orion.fi/en/

Latest From Orion Corporation

Orion Pushing Ahead In Prostate Cancer, R&D Reorganized

Finland’s Orion Corporation is highlighting its prostate cancer and other oncology candidates in its reorganized R&D.

Cancer Research and Development Strategies

Deal Watch: Genentech Gets Access To X-Chem’s DNA-Encoded Library Technology

Genentech will use the X-Chem platform to obtain leads against multiple oncology targets. Lilly partners with Merus on CD3-targeting T-cell therapy candidates.

Deals Business Strategies

Deal Watch: Celgene CVR From BMS Buyout Falls Through

Another victim of the COVID-pandemic, Celgene's $9-per-share contingent value right tied to BMS obtaining approval of three drugs goes unrealized due to FDA travel restrictions slowing down site inspections. Clene goes public, United Therapeutics buys PRV from Y-mAbs.

Deals Business Strategies

Now Available: Medtech Insight’s Top 100 Ranking Of Companies By Sales And 2021 Outlook

After a year like no other for the global medtech industry, 2021 will present a different set of market challenges for device and diagnostic companies.

Commercial Outlook 2021
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Vaccines
    • Drug Delivery
      • Pulmonary
  • Other Names / Subsidiaries
    • Orion Corporation
    • Orion Diagnostica Oy
    • Orion Pharma
    • Orion Oyj
UsernamePublicRestriction

Register